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DObjectives: Previous work in our institution has indicated that the Technical Performance Score (TPS) is highly
associated with early outcomes in select subsets of procedures and age groups. We hypothesized that the TPS
could predict early outcomes in a wide range of diagnoses and age groups.
Methods: Consecutive patients discharged from January 2011 to March 2013 were prospectively evaluated.
The TPS was assigned according to the discharge echocardiographic findings and the need for reinterventions
in the anatomic area of interest. Case complexity was determined using Risk Adjustment for Congenital Heart
Surgery (RACHS-1) categories. Early mortality and postoperative adverse events were recorded. Relationships
between the TPS and outcomes were assessed after adjusting for the baseline patient characteristics.
Results: The median age of the 1926 patients was 1.8 years (range, 0 days to 68 years). Bypass was used in 1740
(90%); 322 (17%) were neonates, 520 (27%) infants, 873 (45%) children, 211 (11%) adults. TPS was class 1
(optimal) in 956 (50%), class 2 (adequate) in 584 (30%), and class 3 (inadequate) in 226 (12%); 160 patients
(8%) could not be scored. A total of 51 early deaths (2.6%) and 111 adverse events (5.7%) occurred.
On univariate analysis, age, RACHS-1 category, and TPS were significantly associated with mortality and
the occurrence of adverse events. On multivariate modeling, class 3 (inadequate) TPS was strongly associated
with mortality (odds ratio, 16.9; 95% confidence interval, 6.7-42.9; P< .001), adverse events (odds ratio,
6.9; 95% confidence interval, 4.1-11.6; P < .001), and postoperative intensive care unit length of stay
(coefficient, 2.3; 95% confidence interval, 2.0-2.6; P<.001) after adjusting for other covariates.
Conclusions: The TPS is strongly associated with early outcomes across a wide range of ages and disease
complexity and can serve as important tool for self-assessment and quality improvement. (J Thorac Cardiovasc
Surg 2014;147:389-96)Supplemental material is available online.
Multiple factors appear to influence the outcomes after
congenital cardiac surgery, with success dependent on
several components. These components include (1) preope-
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The Journal of Thoracic and Caof the patient, complexity of the defect, adequacy of
diagnostic evaluation, and appropriateness of the surgical
plan1; (2) intraoperative factors, such as cardiopulmonary
bypass, surgical technique, and hemodynamic manage-
ment2-4; and (3) postoperative course, including intensive
care unit (ICU) events. Among these many factors, the
technical adequacy of the repair is likely a significant
determinant of a successful outcome.
More than 33,000 surgical procedures are performed
annually for congenital heart defects in the United States.5
Data from the Centers for Disease Control and Prevention6
website have shown that the healthcare costs for hospitali-
zations for congenital heart defects in the United States
were about $1.4 billion in 2004, with severe congenital
heart defects accounting for 37% ($511 million) of the
hospital costs associated with congenital heart defects.
The Technical Performance Score (TPS) is a novel tool
for assessing operative performance. In previous work at
our institution, we developed and validated the TPS initially
for 5 procedures.7-9 The TPS was further validated in a
prospective study of neonates and infants.2,10 We haverdiovascular Surgery c Volume 147, Number 1 389
Abbreviations and Acronyms
AUC ¼ area under the receiver operating
characteristics curve
CI ¼ confidence interval
ICU ¼ intensive care unit
RACHS-1 ¼ Risk Adjustment in Congenital Heart
Surgery
TPS ¼ Technical Performance Score
VSD ¼ ventricular septal defect
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Dsubsequently developed TPS modules to assess>90% of
congenital cardiac procedures.11,12 The purpose of the
present study was to assess the utility of TPS for a wide
range of procedures, from simple to complex, in a
prospective fashion.METHODS
Consecutive patients who were admitted after congenital heart surgery
from January 2011 to March 2013 were included and prospectively
followed up from admission to discharge. The institutional review board
approved the present study. Only the index surgery per admission was
included in the analysis. The TPS was assigned according to the discharge
echocardiographic findings and/or the need for surgical or catheter-based
reinterventions in the anatomic area of interest. The Risk Adjustment for
Congenital Heart Surgery (RACHS-1) category was used to determine
the case complexity. Major postoperative adverse events (excluding
unplanned reinterventions) and mortality were recorded. The length of
time on the ventilator, ICU stay, and postoperative hospital stay were
recorded. Additional information on risk factors such as prematurity,
presence of chromosomal anomalies, and other noncardiac anomalies,
and patient demographics such as age and gender were documented.
Technical Performance Score
The TPS was assigned according to the echocardiographic findings
and clinical status at discharge from the index operation. The procedures
were subdivided into components, and each component was scored as
class 1 (optimal), class 2 (adequate), or class 3 (inadequate) using
specific echocardiographic criteria. The final score for each operation
was determined by the subprocedure scores and was considered class 1
(no residual defect, optimal) if all subprocedure scores were optimal,
class 2 (minor residual, adequate) if 1 subprocedures were adequate,
and class 3 (major residual, inadequate) if 1 subprocedures were graded
as inadequate. Any unplanned reintervention, whether surgical or catheter
based, on the anatomic area initially treated at the index surgery or
the need for permanent pacemaker placement resulted in a class 3
(inadequate) score.1,2,7-12 Only operations or catheter reinterventions
performed on the anatomic area treated at the index operation
(eg, closure of a residual ventricular septal defect [VSD], repeat repair
of a semilunar or an atrioventricular valve, conversion of an
infundibular patch to a transannular patch in valve-sparing tetralogy
repair, branch pulmonary artery stenting after pulmonary artery-plasty)
were considered class 3 (inadequate). Planned reinterventions such as
delayed chest closure and planned pulmonary artery rehabilitation were
not considered TPS class 3. For the purpose of the present study, to avoid
bias and allow inclusion of all patients, we included a fourth category
labeled ‘‘not assigned,’’ for those patients for whom a TPS could not
be assigned because no echocardiogram had been performed, because
the postoperative studies were incomplete, or the involved procedures,390 The Journal of Thoracic and Cardiovascular Surgsuch as vascular rings, pacemakers, ventricular assist device, and others
for which a score has not been developed.
RACHS-1 Mortality Category
The RACHS-1 method was developed to adjust for baseline case mix
differences in risk when comparing in-hospital mortality among groups
of patients aged<18 years undergoing congenital heart surgery. Procedure
and diagnosis codes were used to place the surgical procedures into
6 predefined categories with similar risks of in-hospital mortality. Category
1 had the lowest risk of death and category 6, the highest. Patients with
combinations of cardiac surgical procedures (eg, repair of coarctation of
the aorta and VSD closure) were placed in the risk category corresponding
to the single greatest risk procedure.13,14 For the purposes of the
present study, to include the entire cohort, even those for whom the
RACHS-1 method has not been validated, we created 2 additional
categories—category 7 and category 8. Category 7 included all patients
aged<18 years who could not be assigned a RACHS-1 score. This group
of patients included patients who were aged <18 years, who were
undergoing other complex procedures that could not be assigned a
RACHS-1 category, such as biventricular recruitment, ventricular assist
devices, transplants (eg, heart and lung). Category 8 included all adults.
Outcomes of Interest
The outcomes included in the present analysis were early mortality,
adverse events, and postoperative ICU length of stay. Early mortality
was defined as death in the hospital or death within 30 days of the index
operation if discharged before 30 days. Adverse events included
those events included in the Society of Thoracic Surgeons criteria,15,16
such as (1) the need for extracorporeal membrane oxygenator support;
(2) re-exploration for bleeding; (3) cardiac arrest requiring resuscitation;
(4) re-exploration for hemodynamic instability; (5) diaphragm plication
for paralysis or paresis of the diaphragm; (6) stroke; (7) mediastinitis
requiring exploration and debridement; and (8) renal failure requiring
dialysis. Unplanned surgical or catheter-based reinterventions in the treated
anatomic area and placement of permanent pacemakers were not included
as adverse events, because they are components of the TPS.
Statistical Analysis
Categorical variables are summarized as numbers and percentages and
continuous variables as medians and ranges. The rates of in-hospital
mortality and complications were compared across TPS classes using the
chi-square test, and the postoperative ICU length of stay was compared
using the Kruskal-Wallis test. Similarly, mortality and complication
rates were compared by the baseline patient characteristics using the
chi-square test. The Mann-Whitney U and Kruskal-Wallis tests were
used for the postoperative ICU length of stay. To adjust for baseline patient
characteristics, multivariate logistic and linear regression analysis was
used. For TPS, class 1 (optimal) technical performance was used as the
reference group. For the RACHS-1 categories, categories 1 and 2 were
combined to serve as the reference group (because no deaths or adverse
events occurred in RACHS-1 category 1). In the logistic regression models,
discrimination of the factors for predicting mortality and major postopera-
tive adverse events was assessed using the area under the receiver operating
characteristic curve. For the linear regression model, the coefficient of
determination is presented. A log transformation was applied to the
outcome, postoperative ICU length of stay, because of the skewed distribu-
tion of this variable. IBM SPSS Statistics, version 18, for Windows
(SPSS Inc, Chicago, Ill) was used for statistical analysis.RESULTS
A total of 1926 operations were done in 1714 unique
patients. The baseline patient characteristics for the 1926ery c January 2014
TABLE 1. Patient characteristics
Characteristic Value
Male gender 1059 (55)
Age at surgery
30 d 322 (16.7)
31 d to 1 y 520 (26.9)
1 y to<18 y 873 (45.3)
18 y 211 (10.9)
Weight (kg) 11 (1-147)
Prematurity (<37 wk) 67 (3.4)
Extracardiac and chromosomal anomaly 369 (19.1)
RACHS-1 risk category
1 179 (9.2)
2 526 (27.3)
3 594 (30.8)
4 186 (9.6)
6 62 (3.2)
7 (Could not assign,<18 y) 168 (8.7)
8 (Adults) 211 (10.9)
STS/EACTS category
1 726 (37.6)
2 569 (29.5)
3 138 (7.1)
4 346 (17.9)
5 98 (5.0)
Could not assign 49 (2.5)
TPSs
Class 1, optimal, no residual 956 (49.6)
Class 2, adequate, minor residual 584 (30.3)
Class 3, inadequate, major residual, or predischarge
reintervention
226 (11.7)
NA, TPS score not assigned 160 (8.3)
Early or in-hospital mortality 51 (2.6)
Adverse Events (excluding unplanned reinterventions) 111 (5.8)
Ventilator use (d) 1 (0-424)
ICU stay (d) 2 (0-424)
Hospital (d) 7 (1-424)
Data presented as n (%) for categorical variables and median (range) for continuous
variables. RACHS-1, Risk Adjustment in Congenital Heart Surgery; STS/EACTS,
Society of Thoracic Surgeons/European Association for Cardio-Thoracic Surgery;
TPS, Technical Performance Score; NA, not assigned; ICU, intensive care unit.
TABLE 2. Multivariate modeling for mortality (n ¼ 51/1926)
Variable OR 95% CI P value
RACHS-1 risk category
1-2 1.0 — —
3 2.3 0.6-8.9 .222
4 4.8 1.2-20.4 .031*
6 3.8 0.7-20.9 .126
7 (NA,<18 y) 8.1 2.0-32.4 .003*
8 (Adults) 11.0 1.8-68.8y .010*
Age at surgery
30 d 5.9 2.1-16.9 .001*
31 d to 1 y 3.8 1.4-10.5 .009*
1-18 y 1.0 — —
Prematurity 5.8 2.4-13.9 <.001*
Extracardiac and genetic anomalies 3.1 1.5-6.2 .002*
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Dadmissions are presented in Table 1. A total of 51 deaths
(2.6%) and 111 adverse events (5.8%) occurred, and
the median ICU length of stay for the entire cohort was
2 days (range, 0-424). An unadjusted comparison of the
outcomes based on the TPS is presented in Table E1 and
Figure E1. The relationship between the TPS and
RACHS-1 for mortality and adverse events is presented in
Figure E2.TPS
Class 1, optimal 1.0 — —
Class 2, adequate 0.7 0.2-2.7 .576
Class 3, inadequate 16.9 6.7-42.9 <.001*
NA, TPS not assigned 2.6 0.7-9.7 .151
OR, Odds ratio; CI, confidence interval; RACHS-1, Risk Adjustment in Congenital
Heart Surgery; NA, not assigned; TPS, Technical Performance Score. *Statistically
significant. yOnly 3 deaths occurred in adults, explaining the large 95% CI.Mortality
On univariate analysis, TPS, age, RACHS-1 category,
prematurity, and the presence of chromosomal or other
noncardiac anomalies were all significantly associated
with mortality (P  .001; Table E2). On multivariate
modeling, after adjusting for variables that were significantThe Journal of Thoracic and Caon univariate analysis, the TPS remained strongly
associated with mortality. A class 3 (inadequate) TPS
had an odds ratio of 16.9 (95% confidence interval
[CI], 6.8-42.9; P<.001) for mortality compared with a class
1 (optimal) TPS (Table 2).
Adverse Events and Complications
Similarly, on univariate analysis TPS, age, RACHS-1
category, and prematurity were all significantly associated
with these outcomes (P<.001). However, the presence of
chromosomal or other noncardiac anomalies was not a
significant factor (P ¼ .354; Table E3). On multivariate
modeling, after adjusting for other significant variables,
TPS remained strongly associated with adverse events.
A class 3 (inadequate) TPS had an odds ratio of 6.9 (95%
CI, 4.1-11.7; P< .001) compared with class 1 (optimal)
TPS for adverse events (Table 3).
Postoperative ICU Length of Stay
On univariate analysis, TPS, age, RACHS-1 category,
prematurity, and the presence of chromosomal or other
noncardiac anomalies were all significantly associated
with the postoperative ICU length of stay (P < .001;
Table E4, Figure E3). On multivariate modeling, after
adjusting for these significant variables, the TPS remained
strongly associated with the postoperative ICU length of
stay (P<.001). A class 3 (inadequate) TPS had a coefficient
of 2.3 (95% CI, 2.0- 2.6; Table 4).
We performed a subgroup analysis of the patients
with TPS class 3 (inadequate). In the entire cohort of
1926 patients, 226 (12%) had class 3 (inadequate) TPS.rdiovascular Surgery c Volume 147, Number 1 391
TABLE 3. Multivariate modeling for adverse events (n ¼ 111/1926)
Variable OR 95% CI P value
RACHS-1 risk category
1-2 1.0 — —
3 2.5 1.2-5.5 .018*
4 6.6 2.9-15.0 <.001*
6 7.7 2.8-21.2 <.001*
7 (NA,<18 y) 7.4 3.2-17.5 <.001
8 (Adults) 2.6 0.7-9.0 .139
Age at surgery
30 d 3.0 1.6-5.7 .001*
31 d to 1 y 2.7 1.5-4.8 .001*
1-18 y 1.0 — —
Prematurity 2.9 1.4-6.0 .004*
Extracardiac and genetic anomalies 1.2 0.7-2.0 .516
TPS
Class 1, optimal 1.0 — —
Class 2, adequate 0.7 0.4-1.4 .346
Class 3, inadequate 6.9 4.1-11.7 <.001*
NA, TPS not assigned 1.0 0.4-2.5 .977
OR, Odds ratio; CI, confidence interval; RACHS-1, Risk Adjustment in Congenital
Heart Surgery; NA, not assigned; TPS, Technical Performance Score. *Statistically
significant.
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DAmong the 139 patients undergoing surgical or catheteri-
zation reintervention, 21 (15%) were assigned TPS
class 3 because of the need for a permanent pacemaker.
The distribution of TPS echocardiographic scores in the
pacemaker patients was 29% class 1 (optimal), 57% class
2 (adequate), and 14% class 3 (inadequate). Of the other
118 patients (85% of reinterventions) who had undergone
an unplanned surgical or catheter-based reintervention
(excluding pacemakers) and were therefore placed in class 3TABLE 4. Multivariate modeling for postoperative ICU length of stay
as surrogate for resource usage (n ¼ 1926)
Variable Coefficient 95% CI P value
RACHS-1 risk category
1-2 — — —
3 1.7 1.6-1.9 <.001
4 2.3 2.0-2.7 <.001
6 2.8 2.2-3.5 <.001
7 (NA and age<18 y) 2.3 2.0-2.7 <.001
8 (Adults) 1.4 1.2-1.6 <.001
Age at surgery
30 d 2.6 2.3-3.0 <.001
30 d to 1 y 1.6 1.5-1.8
Prematurity 1.8 1.4-2.2 <.001
Extracardiac defect 1.2 1.1-1.3 <.001
TPS
Class 1, optimal — — —
Class 2, adequate 1.2 1.1-1.3 <.001
Class 3, inadequate 2.3 2.0-2.6 <.001
NA, TPS not assigned 0.8 0.7-1.0 .024
All P values were statistically significant. R2 ¼ 40%. CI, Confidence interval;
RACHS-1, Risk Adjustment in Congenital Heart Surgery; NA, not assigned;
TPS, Technical Performance Score; ICU, intensive care unit.
392 The Journal of Thoracic and Cardiovascular Surg(inadequate), 101 (86%) had preintervention echocardio-
grams that could be coded, and all belonged to class 3
(inadequate). The remaining 17 patients (14%) either had
echocardiograms that could not be classified or had
no echocardiogram but had undergone an unplanned
reintervention because of clinical indications.
All analyses were repeated using only the 1714 unique
patients, and the findings were similar, with TPS an
independent predictor for mortality, complications, and
postoperative ICU length of stay after adjusting for other
important predictive variables.
The robustness of the models in predicting outcomes is
presented in Figure 1. The model for mortality had an
area under the receiver operating characteristics curve
(AUC) of 0.92 (95% CI, 0.88-0.96), and the model for
adverse events had an AUC of 0.86 (95% CI, 0.82-0.89).
The addition of TPS increased the AUC from 0.87 to 0.92
for mortality and from 0.81 to 0.86 for adverse events.
DISCUSSION
In previous work, we have demonstrated that class 1
(optimal) technical performance was associated with lower
adverse event rates and a lower postoperative ICU length of
stay2 and that class 1 (optimal) TPS was able mitigate the
effects of the preoperative severity of illness in a specific
subset of high-risk procedures (ie, stage I Norwood
procedure).1,9 An association was also found between
TPS and midterm outcomes.10,17
The present study has demonstrated the ability of TPS to
predict early outcomes such as mortality, adverse events,
and increased resource use in a diverse set of patients in a
single institution. We included all consecutive patients in
the present study, and the greater power allowed for better
risk adjustment. We were also able to include other
important preoperative variables such as prematurity, age,
and presence of genetic and other noncardiac anomalies
in our model, which have previously been shown to play
important roles in the outcomes after congenital cardiac
surgery.18-20 We chose not to include intraoperative
variables and postoperative variables in our analysis
because of the high co-linearity between the TPS and these
variables.
Although mortality has been routinely used as an
important benchmark of a center’s performance, advances
in surgical technique in the past 2 decades have significantly
improved survival. Therefore, mortality has become less
useful in comparisons between hospitals for performance
evaluation.18 The TPS might thus serve as an important
bench mark for evaluation of each center’s performance.
Congenital cardiac surgery admissions (admissions
included both medical and surgical) have a reported
complication rate as great as 32%.19,20 Furthermore, these
studies showed a greater risk of mortality in patients with
complications after adjusting for other importantery c January 2014
FIGURE 1. Area under the receiver operator characteristics (ROC) curve (AUC) for mortality and adverse events. Top, ROC curves for mortality,
with (left), the entire model and (right), curve for Technical Performance Score. Bottom, ROC curves for adverse events, with (left), the entire model
and (right), the ROC curve for Technical Performance Score. RACHS-1, Risk adjustment in congenital heart surgery; CI, confidence interval.
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of 5.8% related to the use of the more stringent Society
of Thoracic Surgeons criteria for adverse events, with
additional exclusion of unplanned surgical and catheter
reinterventions and unplanned permanent pacemaker
placement. Despite these lower rates, the TPS had a
strong association with the occurrence of adverse events,
with an odds ratio of 6.8 and the TPS having an AUC of
0.69 (Figure 1). Early recognition of an inadequate repair
and intervention, perhaps even in the operating room, might
help reduce the complication rate and associated mortality.2
Congenital heart disease has been well documented to be
associated with high resource usage.6 Furthermore,
mortality and complications after congenital heart surgery
are known to be associated with greater resource use.21
Although healthcare costs remain an important measure
of resource use, the psychosocial effect of prolonged
hospitalization and/or multiple complications and mortality
might well be more important20,22 in the long term for both
patients and family. The TPS, with its ability to predictThe Journal of Thoracic and Camidterm outcomes such as postdischarge mortality and
unplanned reinterventions,10,17 might thus serve as a tool
that recognizes a subgroup of patients who need closer
monitoring.
Our subgroup analysis of patients with TPS class 3
(inadequate) showed that a little less than two thirds
(62%) were assigned a TPS class 3 (inadequate) only
because of the need for unplanned reinterventions and not
from echocardiographic class 3 (inadequate) results.
Among those for whom the unplanned reintervention was
in the treated anatomic area at the index operation, 86%
had had echocardiograms before the reintervention that
were scored as class 3 (inadequate), clearly indicating a
strong association between technical adequacy and the
need for reintervention.
It was also interesting to note that among the RACHS-1
categories, as expected, the RACHS-1 category 6 had
greater mortality and adverse events and a longer post-
operative ICU length of stay. Although this was expected,
we also noted that those in RACHS-1 category 7rdiovascular Surgery c Volume 147, Number 1 393
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category could not be assigned) also had greater mortality
and adverse events and a longer postoperative ICU length
of stay. This could have been because this group
predominantly consisted of patients who have undergone
more complex procedures, such as biventricular recruitment
in hypoplastic left heart, biventricular conversion after
single ventricle palliation, VADS for end-stage heart
failure, and certain complex heart and lung transplants.Study Limitations
The present study represents a single center’s experience
with validation of the TPS. Testing the reproducibility of
this tool across multiple centers is necessary. Furthermore,
validation of the association of TPS with long-term
outcomes is required. We are in the process of collecting
long-term prospective data for this cohort. Although the
present study included larger numbers of patients in each
of the RACHS-1 categories, ideally, the association
between TPS and early outcomes should be studied in
individual procedural groups. We are currently involved
in a multicenter study to validate the TPS prospectively in
specific procedural groups, and we anticipate that this will
allow us to weight each component of the score and
determine the predictive value of each component. This
information will be particularly important, because it would
allow the TPS to be used as a tool that can help determine
which patient would warrant early intervention to avoid
morbidity.CONCLUSIONS
The TPS has been shown to have a strong association with
early outcomes such as mortality, adverse events, and
increased resource use. It might thus allow the development
of predictors for early intervention for residual anatomic
problems.We speculate that it could lead to an improvement
in the long-term physical, neurologic, and psychosocial
development in this vulnerable high-risk population by
identifying patients who would benefit from early interven-
tion and decrease the burden of prolonged illness on patients
with congenital heart disease and their families.
We would like to acknowledge Emile Bacha, MD, and Kathy
Jenkins, MD, for their contributions to the development of the
technical performance score.References
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Dr Christopher A. Caldarone (Toronto, Ontario, Canada).
My only disclosure is that I am a fan of technical performance
scores.
‘‘Mirror, mirror on the wall, who’s the fairest of them all,’’ so
said the witch. She wanted to know how she stacked up against
her peers. How did her blemishes compare to the blemishes of
others? As surgeons, we all want to know the same. Aside fromery c January 2014
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to compare the residual lesions we commonly leave behind.
Dr Nathan and her team should be congratulated for extending
the pioneering work of Emile Bacha in developing the concept of
technical performance scores, a systematic approach to identifying
the significance of residual lesions. You have shown us that
residual lesions are common, and they contribute to mortality.
This is a deceptively simple, yet transformative, concept, a mirror
that we all need.
I have a few questions that will focus on a critique of the
method.
First, your team evaluates numerous components for the
surgical procedure and grades each component into 3 categories.
This approach provides simplicity but results in inevitable loss
of important information. Supporting this notion is your finding
that there is very little difference between the adequate and
optimal score categories—suggesting a loss of information by
categorization. Why did you not create a scoring system in which
continuous variables are maintained and derive a score that is itself
a continuous variable? This would avoid potentially sensitive
terms such as ‘‘inadequate’’ and provide greater discrimination
of outcomes.
Second, your methodology includes the laudable concept of
downgrading a technical performance score to match the lowest
component score. This is based on the premise that each
component has equal clinical significance. However, the clinical
significance of 1 residual lesion could be different from another.
How will you refine your scoring system in the future to take
into account the difference in clinical significance of these various
components?
Third, in the current version of your scoring system, when a
region is not addressed by the surgeon, it is not included in the
TPS. Thus, a patient with residual tricuspid insufficiency, for
example, is included in the scoring system if the surgeon addressed
the tricuspid valve but is not included in the scoring system if the
surgeon chose not to address the residual lesion. Although this
approach keeps the scoring system focused on the interventions
of the surgeon, it ignores the effect of untouched residual lesions,
which are of importance to the patient. Dr Nathan, should an
assessment of surgical performance be limited to the subroutines
performed by the surgeon or should performance be determined
by the patient’s overall freedom from residual lesions?
Finally, as you know, the Congenital Heart Surgeons Society, in
collaboration with members of your team, has developed a web-
based data entry system to provide a technical performance
‘‘mirror’’ for our participants. This system will provide new
information for us to improve our patient care, but it is not clear
how we will transform the concept of a TPS into improved
outcomes. How do you distribute, discuss, and use TPS in Boston
to improve patient outcomes? I want to thank the Association for
the privilege to discuss this study.
Dr Nathan. Thank you, Dr Caldarone. Let me answer your first
question, which was why we use a categorical system of scoring.
The reason we chose a categorical system of scoring is because
it is easily reproducible and can be used across centers. Although
this does lead to some loss of information, this will allow us to
test and validate the score across multiple institutions. We are
actually in the process of accruing patients for a prospectiveThe Journal of Thoracic and Camulti-institutional trial. However, it is important that we also
consider other methods of assessing this score.
Your second question was why all components are scored
equally, and I agree with you that this is something that needs
clarification. For example, a residual VSD in tetrology of Fallot
is an entirely different beast than a residual VSD in primary
VSD repairs. If you had a large residual VSD in tetrology of Fallot,
the patients tend to do worse. Now that we have gathered data for
about 2 to 3 years, we are studying the subcomponents for
each procedure, and we are going to determine which of these
subcomponents is important for each procedure. Hopefully, we
will have the analysis in a year or 2.
Your third question was related to why we did not score residual
lesions that are not intervened on. When we initially started the
score, the plan was to assess the intent to treat, but only the
components that the surgeon operated on were assessed. But I
do agree with you, for example, in a VSD, if after a repair, you
were left with greater than mild tricuspid regurgitation, I think
the score would be inadequate, and we are in the process of
refining the score to reflect this.
Your final question had been about how we used the score to
assess how well we did. We have weekly conferences, and we
review each of the surgeon’s scores and determine how a
procedure that had an inadequate score could have been
performed better. We also have monthly mortality and morbidity
conferences. Currently, we now assign scores for the intraoperative
echocardiograms, and we will compare these with the discharge
echocardiograms. Perhaps that will help us determine when the
intervention needs to be done; thus, this tool could serve not
only as an assessment tool, but also as an interventional tool.
I hope I answered all your questions.
Dr Caldarone. You did.
Dr Francois G. Lacour-Gayet (New York, NY). Dr Nathan, I
enjoyed very much your presentation, and we have followed this
TPS that was initiated by Dr Bacha with great interest. I have a
question of method. How can you predict early death using a
discharge echocardiogram?
Dr Nathan. I know that is an important question. Currently, the
tool is just a retrospective assessment of outcomes based on the
discharge echocardiogram. This is one of the reasons we are taking
more interest in the intraoperative score, because I think the
intraoperative score will be able to help us determine what needs
to be done to prevent mortality.
Glenn Van Arsdell (Toronto, Ontario, Canada). That was a
beautiful study, and I fully agree with it but have a little caveat.
One year ago, we presented a similar controversial report that
suggested if you chase after all these residual lesions in the opera-
ting room, you shift error to the ICU and that the intensive care
performance also affects the outcome. I think back to a book
from your institution in 1994 in which Aldo Castaneda said,
nowhere in the practice of medicine is it more important to have
a harmonious action between many different segments of medi-
cine, intensive care, anesthesia, perfusion, nursing, and so forth.
Why do you suppose in your study we do not see that
importance? It appears in your study that it really is only surgical
performance that matters, not diagnostic performance, not
intensive care performance. In our study, we saw each of those
components being very important.rdiovascular Surgery c Volume 147, Number 1 395
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role in the ultimate outcome; however, if a procedure is done well,
I think it can mitigate some of these effects. In a previous study, we
had shown that in the stage I population, if they had an optimal
score, it was able to mitigate the effects of preoperative status,
as determined by Pediatric Risk of Mortality scores and also
postoperative status determined by Pediatric Risk of Mortality
and other ICU variables.
Also, although all components shown in this chart are
important for outcomes, I think the TPS perhaps has a more
important role to play. If you can achieve a good operation, I think
you minimize a number of the problems seen in the postoperative
period.
Dr Carl L. Backer (Chicago, Ill). I congratulate you on
using this TPS to try and improve the quality of our outcomes.396 The Journal of Thoracic and Cardiovascular SurgThe question I have is, do you have information about what the
surgeon did with the intraoperative transesophageal echocardio-
graphic results? Your performance score mostly relies on
echocardiographic residual lesions. We use intraoperative
transesophageal echocardiogram to identify residual lesions, and
then, in a certain percentage of our patients, we correct those
residual lesions immediately in the operating room. What
percentage of patients underwent attempts to address those
residual lesions in the operating room at the original procedure
according to an intraoperative transesophageal echocardiogram?
Dr Nathan. We are studying that data now; however,
approximately 3% to 4% had a return to bypass to fix a residual
lesion, and this is mostly related to valve repairs. That is why it
is important that we consider those intraoperative scores and
discharge scores and see what the difference is in outcomes.ery c January 2014
FIGURE E1. Mortality and adverse events according to Technical Performance Score (TPS). The number of events and total number of patients in each
group is presented above each bar. NA, Technical performance score could not be assigned.
FIGUREE2. Postoperative intensive care unit (ICU) length of stay according to Technical Performance Score (TPS). The postoperative intensive care unit
length of stay for each TPS class is represented as a box plot. The outliers are represented by asterisks and open circles. The median is represented by the line
in the center of each box, and the whiskers represent the 25th and 75th percentile. Class 3 (inadequate) TPS had a significantly greater median length of stay
(LOS). NA, No TPS score could be assigned; RACHS, Risk Adjustment in Congenital Heart Surgery.
FIGURE E3. Mortality and adverse events across Risk Adjustment for Congenital Heart Surgery (RACHS-1) category according to the Technical
Performance Score (TPS). The percentage of early mortality and adverse events in each TPS class using the RACHS-1 category. Class 3 (inadequate)
TPS was significantly associated with greater rates of mortality and adverse events across RACHS-1 categories 2 and more, with the higher RACHS-1
categories having greater events rates. NA &<18 years, Patients aged<18 years who could not be assigned a RACHS-1 category. ICU, Intensive care
unit; LOS, length of stay.
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TABLE E1. Unadjusted comparison of outcomes according to technical performance score (n ¼ 1926)
Variable
TPS
Class 1
(optimal; n ¼ 956)
Class 2
(adequate; n ¼ 584)
Class 3 (inadequate;
n ¼ 226)
NA (TPS not assigned;
n ¼ 160)
In-hospital mortality 6/956 (0.6) 3/584 (0.5) 36/226 (15.9) 6/160 (3.8)
Adverse events 29/956 (3.0) 14/584 (2.4) 60/226 (26.5) 8/160 (5.0)
Postoperative ICU LOS 2 (0-366) 3 (1-98) 8 (1-424) 1 (0-376)
Categorical variables presented as n (%) and continuous variables as median (range). Class 3 (inadequate) TPS had a P<.001 for all outcomes. TPS, Technical Performance
Score; NA, not assigned; ICU, intensive care unit; LOS, length of stay.
TABLE E2. Univariate analysis of in-hospital mortality (n ¼ 51/1926)
Variable Total
In-hospital
death (n)
Mortality
rate (%)
P
value
TPS <.001*
Class 1, optimal 956 6 0.6
Class 2, adequate 584 3 0.5
Class 3, inadequate 226 36 15.9
NA, no TPS could be assigned 160 6 3.8
RACHS-1 risk category <.001*
1 179 0 0.0
2 526 3 0.6
3 594 13 2.0
4 186 14 7.5
6 62 5 8.1
7 (NA, age<18 y) 168 14 8.3
8 (Adults) 211 2 1.4
Age at surgery <.001*
30 d 322 25 7.8
31 d to 1 y 520 17 3.3
1-18 y 873 6 0.7
Prematurity <.001*
Yes 67 13 19.4
No 1859 38 2.0
Extracardiac and/or genetic anomaly .001*
Yes 369 19 5.1
No 1557 32 2.1
Patients age 18 years constituted both RACHS-1 risk category NA and adult
and age at surgery category 18 years; these 211 patients were included
under RACHS-1 risk category only (category 8). TPS, Technical Performance
Score; RACHS-1, Risk Adjustment in Congenital Heart Surgery; NA, not assigned.
*Statistically significant.
TABLE E3. Univariate analysis of adverse events (n ¼ 111/1926)
Variable Total
In-hospital
adverse
events (n)
Adverse
event
rate (%)
P
value
TPS <.001*
Class 1, optimal 956 29 3.0
Class 2, adequate 584 14 2.4
Class 3, inadequate 226 60 26.5
NA, no TPS could be
assigned
160 8 5.0
RACHS-1 risk category <.001*
1 179 0 0.0
2 526 10 1.9
3 594 29 4.9
4 186 31 16.7
6 62 14 22.6
7 (NA, age<18 y) 168 23 13.7
8 (Adults) 211 4 1.9
Age at surgery <.001*
30 d 322 48 14.9
31 d to 1 y 520 36 6.9
1-18 y 873 23 2.6
Prematurity <.001*
Yes 67 16 23.9
No 1859 95 5.1
Extracardiac and/or genetic anomaly .354
Yes 369 25 6.81
No 1557 86 5.5
Patients aged 18 years constituted both RACHS-1 risk category NA and Adult and
age at surgery category18 years; these 211 patients were included under RACHS-1
risk category (category 8) only. TPS, Technical Performance Score; RACHS-1, Risk
Adjustment in Congenital Heart Surgery; NA, not assigned. *Statistically significant.
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TABLE E4. Univariate analysis for median postoperative ICU length
of stay as surrogate for resource usage (n ¼ 1926 admissions)
Total (n)
Median
postoperative
ICU LOS P value
TPS <.001*
Class 1, optimal 956 2 (0-366)
Class 2, adequate 584 3 (1-98)
Class 3, inadequate 226 8 (1-424)
NA, not able to assign TPS 160 1 (0-376)
RACHS-1 risk category <.001*
1 179 1 (0-366)
2 526 2 (0-365)
3 594 3 (1-256)
4 186 7 (1-270)
6 62 12 (1-70)
7 (NA and age<18 y) 168 5 (1-424)
8 (Adults) 211 2 (1-28)
Age at surgery <.001*
30 d 322 7 (1-376)
31 d to 1 y 520 3 (0-424)
1-18 y 873 2 (0-366)
Prematurity <.001*
Yes 67 8 (1-376)
No 1859 2 (0-424)
Extracardiac and/or genetic anomaly <.001*
Yes 369 3 (1-424)
No 1557 2 (0-424)
Data in parentheses are ranges. Adults were analyzed only once as a part of the
RACHS-1 category (category 8). TPS, Technical Performance Score; RACHS-1,
Risk Adjustment in Congenital Heart Surgery; NA, not assigned; ICU, intensive
care unit; LOS, length of stay. *Statistically significant.
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